Pulmonary fibrosis results from a plethora of abnormal pathogenetic events. In idiopathic
pulmonary fibrosis (IPF), inhalational, environmental, or occupational exposures in …

Idiopathic pulmonary fibrosis (IPF) is the most common fibrotic form of idiopathic diffuse lung
disease. Due to limited treatment options, IPF patients suffer from poor survival. About ten …

Objective Randomized controlled trials comparing tocilizumab and baricitinib in patients with
coronavirus disease 2019 (COVID-19) are needed. This was an open-label, randomized …

Introduction Post-acute sequelae of COVID-19 seem to be an emerging global crisis.
Machine learning radiographic models have great potential for meticulous evaluation of post …

Autotaxin (ATX) or Ectonucleotide Pyrophosphatase/Phosphodiesterase 2 (ENPP2) is a
secreted enzyme with lysophospholipase D activity, with its primary function being the …

Background Data on the safety and efficacy profile of tocilizumab in patients with severe
COVID-19 needs to be enriched. Methods In this open label, prospective study, we …

The role of immunity in the pathogenesis of various pulmonary diseases, particularly
interstitial lung diseases (ILDs), is being increasingly appreciated as mechanistic …

Novel coronavirus pneumonia (COVID-19) is spreading worldwide, causing great harm and
stress to humans. Since patients with novel coronavirus (SARS-CoV-2) have a high …

The pathogenesis of sepsis involves complex interactions and a systemic inflammatory
response leading eventually to multiorgan failure. Autotaxin (ATX, ENPP2) is a secreted …

Purpose Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is the primary cause of
death in patients with IPF, characterised by diffuse, bilateral ground-glass opacification on …